» Authors » Peter Pietschmann

Peter Pietschmann

Explore the profile of Peter Pietschmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 149
Citations 2269
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Dovjak P, Iglseder B, Rainer A, Dovjak G, Weber M, Pietschmann P
Aging Clin Exp Res . 2023 Apr; 35(6):1221-1230. PMID: 37093523
Background: A mere 25% of patients who need treatment for osteoporosis receive appropriate therapy, partly due to the time-consuming and stressful diagnostic workup for older patients with functional decline. Aims:...
12.
Gollmann-Tepekoylu C, Graber M, Hirsch J, Mair S, Naschberger A, Polzl L, et al.
Circulation . 2023 Apr; 147(20):1518-1533. PMID: 37013819
Background: Calcific aortic valve disease (CAVD) is characterized by a phenotypic switch of valvular interstitial cells to bone-forming cells. Toll-like receptors (TLRs) are evolutionarily conserved pattern recognition receptors at the...
13.
Kerschan-Schindl K, Schramek V, Butylina M, Foger-Samwald U, Pietschmann P
Biology (Basel) . 2022 Dec; 11(12). PMID: 36552348
By expressing different genes and proteins that regulate osteoclast as well as osteoblast formation, osteocytes orchestrate bone metabolism. The aim of this project was the evaluation of the differences in...
14.
Leutner M, Butylina M, Matzhold C, Klimek P, Cuhaj C, Bellach L, et al.
Biomed Pharmacother . 2022 Dec; 158:114089. PMID: 36538862
Background: Combining mouse experiments with big data analysis of the Austrian population, we investigated the association between high-dose statin treatment and bone quality. Methods: The bone microarchitecture of the femur...
15.
Kerschan-Schindl K, Papageorgiou M, Foger-Samwald U, Butylina M, Weber M, Pietschmann P
Int J Mol Sci . 2022 Dec; 23(23). PMID: 36498911
It remains uncertain which skeletal sites and parameters should be analyzed in rodent studies evaluating bone health and disease. In this cross-sectional mouse study using micro-computed tomography (µCT), we explored:...
16.
Messner Z, Carro Vazquez D, Haschka J, Grillari J, Resch H, Muschitz C, et al.
J Clin Endocrinol Metab . 2022 Nov; 108(5):1154-1165. PMID: 36408612
Context: MicroRNAs (miRNAs)-short, single-stranded, noncoding RNAs-regulate several biological processes, including bone metabolism. Objective: We investigated circulating miRNAs as promising biomarkers for treatment monitoring in women with postmenopausal osteoporosis on denosumab...
17.
Dimai H, Johansson H, Harvey N, Lorentzon M, Liu E, Vandenput L, et al.
Arch Osteoporos . 2022 Nov; 17(1):141. PMID: 36357621
Purpose: The aim of this study is to provide a reference document for the further development of existing guidelines for the management of osteoporosis in Austria, considering FRAX-based intervention thresholds...
18.
Nebot E, Martinez R, Kapravelou G, Sanchez C, Llopis J, Aranda P, et al.
Nutrients . 2022 Sep; 14(18). PMID: 36145048
The association of obesity with changes in bone mass is not clear. Obese individuals tend to have an increased bone mineral density, but other studies have shown that obesity is...
19.
Meshcheryakova A, Zimmermann P, Salzmann M, Pietschmann P, Mechtcheriakova D
Int J Mol Sci . 2022 Sep; 23(18). PMID: 36142362
The systemic nature of COVID-19 with multiple extrapulmonary manifestations of disease, largely due to the wide tissue expression of SARS-CoV-2 major entry factors, as well as the patient-specific features of...
20.
Wadiura L, Butylina M, Reinprecht A, Aretin M, Mischkulnig M, Gleiss A, et al.
J Bone Miner Res . 2022 Sep; 37(11):2156-2164. PMID: 36056473
Metabolic bone disease is a devastating condition in critically ill patients admitted to an intensive care unit (ICU). We investigated the effects of early administration of the antiresorptive drug denosumab...